Here's where AI investments stand today, as well as my thoughts on how investors’ strategies are likely to evolve over the coming year.

As AI moves from hype to reality in the revenue cycle, an upcoming HealthLeaders webinar will provide practical strategies for leveraging the technology to prevent denials, manage workforce changes, ...

Today’s revenue cycle AI is built on statistical patterns, not clinical understanding. For CIOs and CFOs, this creates a hidden factory of rework, risk and revenue leakage. Here’s why a clinical-first ...

Baylor Scott & White Health’s use of AI in the revenue cycle is expected to result in an annualized $42 million net revenue improvement. The large Texas health system of 52 hospitals was able to ...

Few technological revolutions have rivaled AI in scale and speed since the dot-com era of 1995-2000. While tech fundamentals today remain strong and clear of bubble-like conditions, the ongoing AI ...

Focusing on high-quality cash-generating companies always makes sense. There might be a need for some higher AI-related valuations to come down, but that doesn't mean AI spending is in a bubble that's ...

As global enterprises race to deploy large-scale Large Language Models (LLMs) and AI applications, the demand for AI infrastructure is growing exponentially. However, the typical 18-to-24-month ...

Meta Platforms' post-earnings selloff reflects investor concern that its accelerating AI capex cycle could mirror the metaverse bust of 2021-2022. This was exacerbated by the lack of a corresponding ...

With a $3.3 billion deal to acquire Chronosphere—coming on the heels of the planned $25 billion acquisition of CyberArk—the cybersecurity giant is aiming to lay a massively stronger foundation for ...